A cholinergic-adrenergic hypothesis of mania and depression
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cholinergic-adrenergic theory of depression postulates that over-activation of the cholinergic component leads to depression.
“The cholinergic-adrenergic theory of depression postulates that a fine balance exists between cholinergic and noradrenergic systems, and that over-activation of the cholinergic component would lead to depression (Janowsky et al., 1972).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Janowsky et al., 1972
Increasing ACh signaling in humans results in increased symptoms of depression.
“There is strong evidence that increasing ACh signaling in humans results in increased symptoms of depression (Janowsky et al., 1972; Risch et al., 1980).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Janowsky et al., 1972
The lower β2*-nAChR availability in vivo in MDD is likely better explained by increased levels of extracellular ACh rather than by a decrease in the total number of receptors.
“This suggests that, consistent with the cholinergic hypothesis of depression (4), the lower β2*-nAChR availability in vivo is likely better explained by increased levels of extracellular ACh in patients with MDD rather than by a decrease in the total number of receptors.”
From Persistent β <sub>2</sub> *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder (2012) · cites this paper as [4]
Cholinergic hyperactivity plays a role in the pathophysiology of depression and can exacerbate depression-like symptoms in patients and controls.
“First, cholinergic hyperactivity plays a role in the pathophysiology of depression (2–4) and can exacerbate depression-like symptoms in patients and controls (4–6).”
From Persistent β <sub>2</sub> *-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder (2012) · cites this paper as [4]
Cites
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,499 · see citing works
Nelson, W. E. (1960) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(60)90543-3 · Cited by 1,385 · see citing works
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · see citing works
Norepinephrine in Depressive Reactions
Bunney, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,154 · see citing works
Cholinergic mechanisms in the control of behavior by the brain.
Carlton, P. L. (1963) · Psychological Review · doi:10.1037/h0045063 · Cited by 538 · see citing works
Scheel‐Krüger, J. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90121-x · Cited by 401 · see citing works
PSYCHIATRIC SEQUELÆ OF CHRONIC EXPOSURE TO ORGANOPHOSPHORUS INSECTICIDES
Gershon, S., & Shaw, F. H. (1961) · The Lancet · doi:10.1016/s0140-6736(61)92004-9 · Cited by 315 · see citing works
Regular Induction of Hypomania by L-Dopa in “Bipolar” Manic-depressive Patients
Murphy, D. L., Brodie, H. K. H., Goodwin, F. K., & Bunney, W. E. (1971) · Nature · doi:10.1038/229135a0 · Cited by 258 · see citing works
Pfeiffer, C. C., & Jenney, E. H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40764.x · Cited by 196 · see citing works
THE EFFECTS OF DIISOPROPYLFLUOROPHOSPHONATE IN SCHIZOPHRENIA AND MANIC DEPRESSIVE PSYCHOSIS
Rowntree, D. W., Nevin, S., & Wilson, A. (1950) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.13.1.47 · Cited by 185 · see citing works
SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINKSTERASE ADMINISTRATION
HOWKRS, M. B., GOODMAN, E., & Sim, V. M. (1964) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196404000-00009 · Cited by 172 · see citing works
Use of Body Measurements in the School Health Program
Stuart, H. C., & Meredith, H. V. (1946) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.36.12.1365 · Cited by 169 · see citing works
The effects and treatment of nerve gas poisoning
Grob, D., & Harvey, A. M. (1953) · The American Journal of Medicine · doi:10.1016/0002-9343(53)90358-1 · Cited by 156 · see citing works
Cholinergic modulation of adrenergic arousal in the developing rat.
Fibiger, H. C., Lytle, L. D., & Campbell, B. A. (1970) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0029741 · Cited by 153 · see citing works
Stein, L., & Himwich, H. E. (1962) · Recent Advances in Biological Psychiatry · doi:10.1007/978-1-4684-8306-2_27 · Cited by 148 · see citing works
Studies of Alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in Depression and Mania
Bunney, W. E., Brodie, H. K. H., Murphy, D. L., & Goodwin, F. K. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.7.872 · Cited by 136 · see citing works
Sulser, F., Bickel, M. H., & Brodie, B. B. (1964) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26795-7 · Cited by 135 · see citing works
CHOLINERGIC REVERSAL OF MANIC SYMPTOMS
Janowsky, D., El‐Yousef, M. K., Davis, J., Hubbard, B. A., & SEKERKE, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90956-7 · Cited by 111 · see citing works
Self-citationRubidium and Lithium: Opposite Effects on Amine-Mediated Excitement
Carroll, B. J., & Sharp, P. T. (1971) · Science · doi:10.1126/science.172.3990.1355 · Cited by 92 · see citing works
Effects of cholinergic drugs on hypothalamic self-stimulation response rates of dogs
Stark, P., & BOYD, E. S. (1963) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1963.205.4.745 · Cited by 80 · see citing works
Theories of Biological Etiology of Affective Disorders
Davis, J. M. (1970) · International review of neurobiology · doi:10.1016/s0074-7742(08)60060-4 · Cited by 70 · see citing works
Self-citationCOMPARISON OF MUSCARINIC AND NICOTINIC CHOLINERGIC AGONISTS ON SELF-STIMULATION BEHAVIOR
OLDS, M. E., & Domino, E. F. (1969) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28223-4 · Cited by 70 · see citing works
A biphasic action of central cholinergic stimulation on behavioral arousal in the rat
Fibiger, H. C., LYNCH, G. S., & Cooper, H. P. (1971) · Psychopharmacology · doi:10.1007/bf00403568 · Cited by 65 · see citing works
EFFECT OF L-DOPA ON DEPRESSION
Bunney, W., Janowsky, D., Goodwin, F., Davis, J., Brodie, H. K. H., Brodie, H. K. H., Murphy, D., & Chase, T. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91921-7 · Cited by 63 · see citing works
Self-citationCHOLINERGIC INHIBITION OF SELF-STIMULATION BEHAVIOR
Domino, E. F., & OLDS, M. E. (1968) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28118-6 · Cited by 61 · see citing works
Yahr, M. D., & Duvoisin, R. C. (1972) · New England Journal of Medicine · doi:10.1056/nejm197207062870105 · Cited by 55 · see citing works
A COMPARISON OF ANTAGONISTS OF PHYSOSTIGMINE-INDUCED SUPPRESSION OF BEHAVIOR
Vaillant, G. E. (1967) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27748-5 · Cited by 54 · see citing works
THE PERSISTANCE OF AMPHETAMINE STEREOTYPIES OF RATS IN SPITE OF STRONG SEDATION
Munkvad, I., & Randrup, A. A. (1966) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1966.tb08802.x · Cited by 52 · see citing works
Low Serum Pseudocholinesterase Levels Complicating Treatment with Phenelzine
Bodley, P. O., Halwax, K., & Potts, L. (1969) · BMJ · doi:10.1136/bmj.3.5669.510 · Cited by 48 · see citing works
Bogdanski, D. F., Sulser, F., & Brodie, B. B. (1961) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26025-6 · Cited by 48 · see citing works
The effect of lithium and amphetamine on desmethylimipramine-Ro 4-1284 induced motor hyperactivity
Matussek, N., & Linsmayer, M. (1968) · Life Sciences · doi:10.1016/0024-3205(68)90006-4 · Cited by 45 · see citing works
Study on the excitation induced by amphetamine, cocaine and ?-methyltryptamine
Galambos, �., Pfeifer, A. K., Gy�rgy, L., et al. (1967) · Psychopharmacology · doi:10.1007/bf00401248 · Cited by 41 · see citing works
Doyle, A. E., McQueen, E. G., & Smirk, F. H. (1955) · Circulation · doi:10.1161/01.cir.11.2.170 · Cited by 39 · see citing works
Effect of Iprindole on Amine Uptake in Man
FANN, W. E. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200062013 · Cited by 39 · see citing works
SOME EFFECTS OF A NEW PSYCHOTOGEN IN DEPRESSIVE STATES
Abood, L. G., & Meduna, L. J. (1958) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195812000-00008 · Cited by 34 · see citing works
Oral Preparations of Rauwolfia Serpentina in Treatment of Essential Hypertension
Locket, S. (1955) · BMJ · doi:10.1136/bmj.1.4917.809 · Cited by 29 · see citing works
Ho, A. K. S., Singer, G., & Gershon, S. (1971) · Psychopharmacology · doi:10.1007/bf00403862 · Cited by 29 · see citing works
Effects of cholinergic drugs on self-stimulation response rates in rats
Jung, O., & Boyd, E. (1966) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1966.210.3.432 · Cited by 27 · see citing works
Mandell, A. J., & Knapp, S. (1971) · Neuropharmacology · doi:10.1016/0028-3908(71)90079-7 · Cited by 21 · see citing works
Pharmacological and Biochemical Comparison of Lithium and Reference Antidepressants
Perkinson, E., Ruckart, R. T., & DaVanzo, J. P. (1969) · Experimental Biology and Medicine · doi:10.3181/00379727-131-33953 · Cited by 19 · see citing works
Studies on the interaction between inhibitors of drug metabolism and horse plasma cholinesterase
Gómez, M. I. D., & Castro, J. A. (1971) · Biochemical Pharmacology · doi:10.1016/0006-2952(71)90313-3 · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404 · see citing works
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767 · see citing works
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674 · see citing works
Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression
Neckelmann, D., Mykletun, A., & Dahl, A. A. (2007) · Sleep · doi:10.1093/sleep/30.7.873 · Cited by 665 · see citing works
Sleep and depression--results from psychobiological studies: an overview
Riemann, D., Berger, M., & Voderholzer, U. (2001) · Biological Psychology · doi:10.1016/s0301-0511(01)00090-4 · Cited by 653 · see citing works
The neuropsychology of 3-D space.
Previc, F. H. (1998) · Psychological Bulletin · doi:10.1037/0033-2909.124.2.123 · Cited by 604 · see citing works
REM sleep dysregulation in depression: state of the art
Palagini, L., Baglioni, C., Ciapparelli, A., Gemignani, A., & Riemann, D. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.11.001 · Cited by 513 · see citing works
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Toward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423 · see citing works
Furey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417 · see citing works
Akiskal, H. S., & McKinney, W. T. (1973) · Science · doi:10.1126/science.182.4107.20 · Cited by 389 · see citing works
Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219731110 · Cited by 375 · see citing works
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369 · see citing works
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279 · see citing works
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · see citing works
Drevets, W. C., & Furey, M. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.021 · Cited by 241 · see citing works
The vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212 · see citing works
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works
Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review
Drevets, W. C., Zarate, C. A., & Furey, M. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.031 · Cited by 195 · see citing works
Neuromodulation by acetylcholine: examples from schizophrenia and depression
Higley, M. J., & Picciotto, M. R. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.06.004 · Cited by 184 · see citing works
Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171 · see citing works
Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior
Warner-Schmidt, J. L., Schmidt, E. F., Marshall, J. J., Rubin, A. J., Arango-Lievano, M., Kaplitt, M. G., Ibañez-Tallon, I., Heintz, N., & Greengard, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209293109 · Cited by 163 · see citing works
Sleep and circadian rhythm dysregulation in schizophrenia
Monti, J. M., BaHammam, A. S., Pandi-Perumal, S. R., Bromundt, V., Spence, D. W., Cardinali, D. P., & Brown, G. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.021 · Cited by 157 · see citing works
Sleep and Antidepressant Treatment
Wichniak, A., Wierzbicka, A., & Jernajczyk, W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523608 · Cited by 142 · see citing works
Risch, S. C., Cohen, R. M., Janowsky, D. S., Kalin, N. H., & Murphy, D. L. (1980) · Science · doi:10.1126/science.7433977 · Cited by 140 · see citing works
Self-citationSleep in psychiatric disorders
Benca, R. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70283-8 · Cited by 139 · see citing works
Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139 · see citing works
Mineur, Y. S., Somenzi, O., & Picciotto, M. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.01.006 · Cited by 137 · see citing works
Scopolamine produces larger antidepressant and antianxiety effects in women than in men
Furey, M. L., Khanna, A., Hoffman, E. M., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.131 · Cited by 138 · see citing works
Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129 · see citing works
George, T. P., Sacco, K. A., Vessicchio, J. C., Weinberger, A. H., & Shytle, R. D. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b49e · Cited by 128 · see citing works
Caldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works
Saricicek, A., Esterlis, I., Maloney, K. H., Mineur, Y. S., Ruf, B. M., Muralidharan, A., Chen, J. I., Cosgrove, K. P., Kerestes, R., Ghose, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11101546 · Cited by 118 · see citing works
Effects of transderman nicotine on mood and sleep in nonsmoking major depresssed patients
Salín-Pascual, R. J., Galicia-Polo, L., Drucker-Colín, R., de la Fuente, J. R., Drucker-Colín, R., & Salín-Pascual, R. J. (1995) · Psychopharmacology · doi:10.1007/bf02246496 · Cited by 113 · see citing works
Lauer, C. J., & Krieg, J.-C. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(02)00122-3 · Cited by 97 · see citing works
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96 · see citing works
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91 · see citing works
Mineur, Y. S., Fote, G. M., Blakeman, S., Cahuzac, E. L. M., Newbold, S. A., & Picciotto, M. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.316 · Cited by 90 · see citing works
Pathophysiology of “cholinoceptor supersensitivity” in affective disorders
Dilsaver, S. C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90246-5 · Cited by 87 · see citing works
Antimuscarinic and Other Receptor-Blocking Properties of Antidepressants
Richelson, E. (1983) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18711-9 · Cited by 84 · see citing works
Sleep and manipulations of the sleep–wake rhythm in depression
Berger, M., Van Calker, D., & Riemann, D. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.17.x · Cited by 82 · see citing works
Riemann, D., Hohagen, F., Bahro, M., & Berger, M. (1994) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191586 · Cited by 79 · see citing works
Cytisine-based nicotinic partial agonists as novel antidepressant compounds
Mineur, Y. S., Eibl, C., Young, G., Kochevar, C., Papke, R. L., Gündisch, D., & Picciotto, M. R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149609 · Cited by 75 · see citing works
Fernandez, S. P., Broussot, L., Marti, F., Contesse, T., Mouska, X., Soiza-Reilly, M., Marie, H., Faure, P., & Barik, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06809-7 · Cited by 75 · see citing works
Dilsaver, S. C., & Greden, J. F. (1984) · Brain Research Reviews · doi:10.1016/0165-0173(84)90028-6 · Cited by 73 · see citing works
Bauer, J., Hohagen, F., Gimmel, E., Bruns, F., Lis, S., Krieger, S., Ambach, W., Guthmann, A., Grunze, H., Fritsch-Montero, R., et al. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00374-x · Cited by 68 · see citing works
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68 · see citing works
Hannestad, J. O., Cosgrove, K. P., DellaGioia, N. F., Perkins, E., Bois, F., Bhagwagar, Z., Seibyl, J. P., McClure-Begley, T. D., Picciotto, M. R., & Esterlis, I. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.004 · Cited by 63 · see citing works
Limon, A., Mamdani, F., Hjelm, B. E., Vawter, M. P., & Sequeira, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.010 · Cited by 63 · see citing works
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51 · see citing works
Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49 · see citing works
Lee, C.-H., & Hung, S.-Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010031 · Cited by 50 · see citing works
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47 · see citing works
Small, K. M., Nunes, E., Hughley, S., & Addy, N. A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.057 · Cited by 43 · see citing works
Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test
Addy, N. A., Nunes, E. J., & Wickham, R. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.002 · Cited by 42 · see citing works
Lyoo, I. K., Demopulos, C. M., Hirashima, F., Ahn, K. H., & Renshaw, P. F. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00041.x · Cited by 33 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168038 · Cited by 22 · see citing works
Benca, R. M. (2005) · Principles and Practice of Sleep Medicine · doi:10.1016/b0-72-160797-7/50119-1 · Cited by 18 · see citing works
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15 · see citing works
- Authors
- Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J.
- Affiliations
- Vanderbilt University (US)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1972-09
- Volume
- 300
- Issue
- 7778
- Pages
- 632-635
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2056272943
- Cited by
- 1,134
- References
- 41
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 16 · 2023: 10 · 2022: 20 · 2021: 26 · 2020: 22 · 2019: 20 · 2018: 24 · 2017: 22 · 2016: 16 · 2015: 31 · 2014: 16 · 2013: 22 · 2012: 27
- FWCI
- 28.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mania, depression, bipolar disorder, acetylcholine, norepinephrine, reserpine, tricyclic antidepressants, physostigmine, cholinomimetic drugs, autonomic nervous system
- MeSH terms
- Affective Symptoms, Autonomic Nervous System, Bipolar Disorder, Depression, Homeostasis, Humans, Synaptic Transmission, Parasympathetic Nervous System, Parasympathomimetics, Schizophrenia, Sympathetic Nervous System, Sympathomimetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review